|Jmol-3D images||Image 2|
|Molar mass||316.480 g/mol|
| (what is: / ?) |
Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa)
JNJ-5207852 is a histamine antagonist selective for the H3 subtype. It has stimulant and nootropic effects in animal studies, and has been suggested as a possible treatment for memory defects associated with epilepsy. JNJ-5207852 itself did not progress to clinical development due to poor pharmacokinetic characteristics, but the related compound JNJ-17216498 is currently in Phase II clinical trials for the treatment of narcolepsy.
|This pharmacology-related article is a stub. You can help World Heritage Encyclopedia by expanding it.|
|This article about an organic compound is a stub. You can help World Heritage Encyclopedia by expanding it.|